Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

聚苯乙烯磺酸钙散剂 - NMPA Drug Approval Details

Approvals/NMPA/Calcium Polystyrene Sulfonate Powder

Approved

化学药品

Calcium Polystyrene Sulfonate Powder

KOWA COMPANY,LTD.🇨🇳 National Medical Products Administration

Approval Date: Sep 17, 2025
Approval ID: 888Q2eoEUAm
Company: KOWA COMPANY,LTD.
Type: 化学药品

Approval Details

Approval Id: 888Q2eoEUAm
Approval Number: 国药准字HJ20150443
Generic Name: 聚苯乙烯磺酸钙散剂
Generic Name En: Calcium Polystyrene Sulfonate Powder
Drug Type: 化学药品
Dosage Form: 散剂
Strength: 5克
Reg Date: 2025-09-17
Expired Date: 2030-09-16
Company Name: KOWA COMPANY,LTD.
Company Detail Path: /organization/kowa-company-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 17, 2025

Approval ID

888Q2eoEUAm

Type

化学药品

Back to NMPA Approvals